Nalaganje...
Efficacy and safety of combination PD‐1/PD‐L1 checkpoint inhibitors for malignant solid tumours: A systematic review
Treatment of multiple malignant solid tumours with programmed death (PD)‐1/PD ligand (PD‐L) 1 inhibitors has been reported. However, the efficacy and immune adverse effects of combination therapies are controversial. This meta‐analysis was performed with PubMed, Web of Science, Medline, EMBASE and C...
Shranjeno v:
| izdano v: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7701512/ https://ncbi.nlm.nih.gov/pubmed/33078904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15991 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|